Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S announces outcome of the Rights Issue
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: A strong and growing organization is ready to fulfill the commercial ambitions
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: Last day of subscription of units in DanCann Pharma A/S ongoing rights issue and guidance on how to subscribe
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S with inspection by the Danish Medicine Agency during Q4-2022: expects to get EU-GMP approval before end-2022
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S’ Board of Directors and Management have subscribed for units in the ongoing Rights Issue
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes a supplement to the prospectus for the rights issue
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q3-2022 report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S signs binding agreement with Polish company Storkpharm worth more than DKK 40 million
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S targeting annual revenue of approx. DKK 60-100 million – and with several new partner agreements in the pipeline
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: The subscription period in DanCann Pharma’s Rights Issue begins today